Topical Cannabidiol Application and Skin Vascular Reactivity
NCT ID: NCT05456113
Last Updated: 2025-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2024-12-01
2026-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain
NCT04193631
A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults
NCT05121506
Kinetics of Etheric Oils, Smart Textiles vs. Ointment
NCT00299559
Effect of an Emollient Cream Containing 0.5% Cannabidiol and 1% Hemp Oil in the Hydration and Erythema of the Skin
NCT04045314
Use of Aromatherapy to Reduce Symptom Burden
NCT05251337
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Vehicle control, does not contain cannabidiol
Cannabidiol
Urbal Activ Extra Strength CBD Body Strong Balm applied to region of forearm to be stimulated by iontophoresis machine
Cannabidiol
Active ingredient experimental arm, contains full spectrum connabidiol
Cannabidiol
Urbal Activ Extra Strength CBD Body Strong Balm applied to region of forearm to be stimulated by iontophoresis machine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cannabidiol
Urbal Activ Extra Strength CBD Body Strong Balm applied to region of forearm to be stimulated by iontophoresis machine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking
* Non-obese class III, BMI ≤ 39.9
* Normal HbA1C of \<6.5%
Exclusion Criteria
* Rash, skin disease, disorders of pigmentation
* Known skin allergies
* Diabetes
* Nicotine use (e.g. smoking, chewing tobacco, vaping, etc.)
* Illegal drug use
* Recent (within the last 30 days) CBD users either topical or oral
* Allergy or hypersensitivity to investigational agents
* Women who are pregnant or breastfeeding
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Penn State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lacy Alexander
Professor of Kinesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Noll Laboratory
University Park, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20515
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.